Serotonin Syndrome in EMS: Recognizing Toxicity Before It Escalates

Disclaimer: This article is for educational purposes only. Always follow your agency's current local protocols and medical direction. Perform assessments and interventions only within your training, scope of practice, and authorized clinical guidelines.

A restless, sweaty patient with a rapid pulse can fit several dispatch complaints. Add a recent medication change and repetitive muscle jerking, and the assessment takes a different direction. Serotonin syndrome belongs on the differential, especially when the medication history and neurologic findings point toward the same problem.

For EMS clinicians, the task is to recognize a concerning pattern, identify deterioration, and begin supportive care while arranging appropriate transport.

Start With What Changed

Serotonin syndrome, also called serotonin toxicity, results from excessive serotonergic activity in the nervous system. Its severity ranges from mild tremor and restlessness to dangerous hyperthermia, muscle rigidity, seizures, and organ injury.

It can follow an overdose, a newly prescribed medication, a dose increase, or an interaction between substances. Symptoms often begin within hours of the triggering exposure, although timing varies. Toxicity can occur with prescribed doses, particularly when interacting medications are combined.

Ask about prescription medications, over-the-counter products, supplements, and recreational substances. Relevant exposures include:

Serotonergic antidepressants, including SSRIs, SNRIs, and monoamine oxidase inhibitors.
Tramadol, a pain medication with serotonergic effects.
Dextromethorphan, found in some cough and cold products.
Linezolid, an antibiotic that can interact with serotonergic medications.
MDMA and supplements such as St. John's wort.

This is not an exhaustive list, and these substances do not carry identical risks. Record what was taken, how much, when, and what recently changed. Medication containers, family observations, and pharmacy lists can help reconstruct an incomplete history.

Look for the Combination of Findings

Serotonin toxicity can affect mental status, autonomic function, and muscle activity. Examine all three rather than making the assessment depend on a single abnormal vital sign.

Mental status: Anxiety, restlessness, agitation, or confusion.
Autonomic findings: Sweating, tachycardia, blood pressure changes, elevated temperature, and sometimes diarrhea.
Neuromuscular findings: Tremor, hyperreflexia, clonus, and, in severe cases, rigidity.

Clonus deserves particular attention. It consists of repetitive, rhythmic muscle contractions that may occur spontaneously or be elicited during examination. Ocular clonus involves involuntary, repetitive eye movements. Clonus and unusually brisk reflexes can provide valuable clues when medication exposure is plausible.

A normal temperature does not exclude mild toxicity. Conversely, a rapidly rising temperature with increasing rigidity signals a potentially life-threatening process. Severe rigidity can also make clonus difficult to demonstrate.

Use Diagnostic Criteria in Context

The Hunter Serotonin Toxicity Criteria organize several characteristic examination patterns. In a patient with a relevant serotonergic exposure, any one of the following combinations supports the diagnosis:

Examination finding	Additional requirement
Clonus occurring spontaneously	No additional finding required
Clonus elicited during examination	Either agitation or sweating
Ocular clonus	Either agitation or sweating
Tremor	Hyperreflexia
Increased muscle tone with temperature above 38°C (100.4°F)	Either ocular clonus or inducible clonus

These criteria were developed using patients with serotonergic overdoses. Apply them alongside the exposure history, the full examination, and consideration of other diagnoses. They are not a universal screening test for every agitated or febrile patient.

There is no laboratory test that confirms serotonin syndrome. Infection, withdrawal, heat illness, other poisonings, and neuroleptic malignant syndrome can produce overlapping findings. Check glucose and continue evaluating alternative causes of altered mental status.

Treat Immediate Threats While Investigating the Cause

Begin with airway, breathing, and circulation. Assess oxygenation, ventilation, perfusion, mental status, and temperature. Obtain cardiac monitoring and a 12-lead ECG when indicated because the exposure may also cause conduction abnormalities or dysrhythmias.

Establish vascular access when appropriate and provide fluids according to the patient's perfusion, hydration status, and local protocols. Prevent additional exposure to suspected causative substances in consultation with medical direction.

Benzodiazepines are commonly used for agitation and seizures. Follow your authorized medication, route, dosing, and reassessment guidance. Monitor breathing and hemodynamics closely after administration. Severe toxicity may require further escalation despite initial sedation.

Track changes throughout transport. A patient who becomes quieter after medication still needs reassessment of ventilation, temperature, muscle tone, and circulation.

Recognize Hyperthermia as an Urgent Threat

Sustained muscle activity contributes to heat production in serotonin toxicity. Antipyretics such as acetaminophen do not address this mechanism and must not delay active cooling or control of excessive muscle activity.

Initiate cooling according to local protocols when clinically indicated, and reassess temperature frequently. Rapidly worsening hyperthermia, severe rigidity, seizures, or impaired ventilation warrant urgent escalation and early notification of the receiving facility.

Severe cases may require intubation, mechanical ventilation, and neuromuscular blockade by appropriately trained and authorized clinicians. These interventions require adequate ongoing sedation. Complications can include rhabdomyolysis, kidney injury, and multiorgan failure.

Understand the Limits of Cyproheptadine

Cyproheptadine has serotonin receptor antagonist activity and is sometimes used as an adjunct under specialist guidance. It is available as an oral formulation, and evidence that it improves important clinical outcomes remains limited.

Decisions about its use belong within medical direction and toxicology consultation. It must not delay airway support, sedation, cooling, or transport.

In the United States, Poison Control is available at 1-800-222-1222. During consultation and handoff, communicate suspected substances, timing, recent medication changes, temperature trends, neuromuscular findings, treatments, and the patient's response. Specific observations help the receiving team continue the assessment and anticipate complications.